Abbott has announced that it has reached a significant settlement agreement with DexCom, Inc., resolving all ongoing patent disputes between the two companies related to continuous glucose monitoring ...

People with type 2 diabetes who are using Ozempic are more likely to develop damage to the optic nerve of the eye compared to those not using the popular drug, research has shown. Scientists from the ...

At entry to the study 43 patients (61%) were using Novopen ® 3 to administer their insulin, 22 (31%) were using syringes, and five (7%) had used a combination of Novopen ® 3 and syringes.